MRKR - Marker Therapeutics GAAP EPS of -$0.55 beats by $0.02 revenue of $1.24M March, 17 2022 06:05 PM Marker Therapeutics Inc. Marker Therapeutics press release (NASDAQ:MRKR): FY GAAP EPS of -$0.55 beats by $0.02. Revenue of $1.24M (+163.8% Y/Y). For further details see: Marker Therapeutics GAAP EPS of -$0.55 beats by $0.02, revenue of $1.24M